» Articles » PMID: 31913967

A Randomized Study Comparing the Short-Term Neurocognitive Outcome of Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in the Treatment of Patients With Depression

Overview
Specialty Psychiatry
Date 2020 Jan 9
PMID 31913967
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have compared electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) with regard to their clinical efficacy in the treatment of depression, but only a few studies have addressed their differential impact on cognition. The purpose of this study was to compare the neurocognitive side effects of both treatment modalities.

Methods: In this comparative study, 40 patients with major depressive disorder referred for ECT were randomly assigned either to a course of 25 sessions of rTMS to the left dorsolateral prefrontal cortex or to a course of ECT ranging from 4 to 8 sessions. The primary outcome measures were the results of a cognitive battery that assessed different aspects of cognitive functioning. The cognitive battery comprised the Digit Span Subtest from the Wechsler Adult Intelligence Scale, the Stroop Color-Word Test-Victoria version, the Color Trails Test Trials 1 and 2, and the Rey-Osterrieth Complex Figure Test.

Results: At the end of treatment, scores on the Digit Span Subtest, the Stroop Color-Word Test-Victoria version, and the Color Trails Test showed statistically significant better results in the rTMS group compared with the ECT group.

Conclusions: rTMS was well tolerated with less negative impact on cognitive functioning than ECT.

Citing Articles

More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression.

Oostra E, Jazdzyk P, Vis V, Dalhuisen I, Hoogendoorn A, Planting C Acta Psychiatr Scand. 2024; 151(4):485-505.

PMID: 39569643 PMC: 11884915. DOI: 10.1111/acps.13768.


The electro-convulsive therapy story of Africa, a systematic review.

Abaatyo J, Kaggwa M Discov Ment Health. 2024; 4(1):31.

PMID: 39251508 PMC: 11383911. DOI: 10.1007/s44192-024-00085-2.


Epigenome Defines Aberrant Brain Laterality in Major Mental Illnesses.

Mostafavi Abdolmaleky H, Nohesara S, Thiagalingam S Brain Sci. 2024; 14(3).

PMID: 38539649 PMC: 10968810. DOI: 10.3390/brainsci14030261.


Circadian Reinforcement Therapy in Combination With Electronic Self-Monitoring to Facilitate a Safe Postdischarge Period for Patients With Major Depression: Randomized Controlled Trial.

Aggestrup A, Svendsen S, Praestegaard A, Loventoft P, Norregaard L, Knorr U JMIR Ment Health. 2023; 10:e50072.

PMID: 37800194 PMC: 10714270. DOI: 10.2196/50072.


The clinical characterization of the adult patient with depression aimed at personalization of management.

Maj M, Stein D, Parker G, Zimmerman M, Fava G, De Hert M World Psychiatry. 2020; 19(3):269-293.

PMID: 32931110 PMC: 7491646. DOI: 10.1002/wps.20771.